12:11 PM EST - Bausch Health Companies Inc. : And its gastroenterology (GI) business, Salix Pharmaceuticals, today announced the opening of the 2025 Salix Gastrointestinal Health Scholars Program application period. The program will award 10 exceptional students living with GI disease a scholarship of up to $10,000 as they work to pursue their higher education goals. Bausch Health Companies Inc.
shares T.BHC are trading down $0.19 at $9.04.
